The Antitumor Activity of Meisoindigo against Human Colorectal Cancer HT-29 Cells In Vitro and In Vivo

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of chemotherapy

• Publication date

  2008-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1179/joc.2008.20.6.728PMID 19129071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 3D QSAR for GSK-3beta inhibition by indirubin analogues.

  2006cited by this paper
• Targeting GSK-3: a promising approach for cancer therapy?

  2006cited by this paper
• 3D QSAR for GSK-3β inhibition by indirubin analogues

  2006cited by this paper
• The role of the Wnt signalling pathway in colorectal tumorigenesis.

  2005cited by this paper
• [Inducement effect of Meisoindigo on apoptosis of leukemia cell line HL-60 and its mechanism].

  2005cited by this paper
• Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine

  2004cited by this paper
• The Wnt signaling pathway in development and disease.

  2004cited by this paper
• Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.

  2004cited by this paper
• GSK-3-selective inhibitors derived from Tyrian purple indirubins.

  2003cited by this paper
• The Wnt signaling pathway and its role in tumor development

  2003cited by this paper
• GSK-3: tricks of the trade for a multi-tasking kinase

  2003cited by this paper
• Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

  2002cited by this paper
• The Wnt signalling pathway

  2002cited by this paper
• Indirubin and Meisoindigo in the Treatment of Chronic Myelogenous Leukemia in China

  2002cited by this paper
• Crystal Structure of Glycogen Synthase Kinase 3β: Structural Basis for Phosphate-Primed Substrate Specificity and Autoinhibition

  2001cited by this paper
• Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition.

  2001cited by this paper
• Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

  1999cited by this paper
• Pharmacological studies of meisoindigo: absorption and mechanism of action.

  1991cited by this paper

• Meisoindigo Acts as a Molecular Glue to Target PKMYT1 for Degradation in Chronic Myeloid Leukemia Therapy

  2025cites this paper
• Discovery of a Meisoindigo-Derived PROTAC as the ATM Degrader: Revolutionizing Colorectal Cancer Therapy via Synthetic Lethality with ATR Inhibitors.

  2024cites this paper
• Nanoliposome-Loaded Phenolics from Nasturtium officinale Improves Health Parameters in a Colorectal Cancer Mouse Model

  2022cites this paper
• Meisoindigo attenuates dextran sulfate sodium-induced experimental colitis via its inhibition of TAK1 in macrophages.

  2021cites this paper
• Isolation and structural elucidation of bioactive obovatol dimeric neolignans from the bark of Magnolia officinalis var. biloba.

  2021cites this paper
• 甲异靛对JAK2/V617F杂合突变细胞系SET2细胞凋亡和增殖作用及其机制的研究

  2019cites this paper
• Pathway-Centric Structure-Based Multi-Target Compound Screening for Anti-Virulence Drug Repurposing

  2019cites this paper
• Meisoindigo Protects Against Focal Cerebral Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation and Regulating Microglia/Macrophage Polarization via TLR4/NF-κB Signaling Pathway

  2019cites this paper
• QSAR treatment of meisoindigo derivatives as a potentbreast anticancer agent

  2019cites this paper
• Recent Advancements in the Clinical Evaluation of Plant-Derived Anticancer Compounds

  2017cites this paper
• Anticancer Plants: Clinical Trials and Nanotechnology

  2017influential citation
• African Plants with Antiproliferative Properties

  2017cites this paper
• LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy

  2015cites this paper
• Antiproliferative activity of the isoindigo 5'-Br in HL-60 cells is mediated by apoptosis, dysregulation of mitochondrial functions and arresting cell cycle at G0/G1 phase.

  2015cites this paper
• The Pyridone-Annelated Isoindigo (5‘-Cl) Induces Apoptosis, Dysregulation of Mitochondria and Formation of ROS in Leukemic HL-60 Cells

  2015cites this paper
• The Anticancer Activity of the Substituted Pyridone-Annelated Isoindigo (5'-Cl) Involves G0/G1 Cell Cycle Arrest and Inactivation of CDKs in the Promyelocytic Leukemia Cell Line HL-60

  2015cites this paper
• 7,7'-Diazaindirubin--a small molecule inhibitor of casein kinase 2 in vitro and in cells.

  2014cites this paper
• Synthesis and Biological Evaluation of New Pyridone-Annelated Isoindigos as Anti-Proliferative Agents

  2014influential citation
• Kinase inhibitors of marine origin.

  2013cites this paper
• Radiosynthesis of N-11C-meisoindigotin as a novel PET agent for imaging of cyclin-dependent kinases and GSK-3β

  2012cites this paper
• Discovery of new anticancer agents from higher plants.

  2012cites this paper
• The continuing search for antitumor agents from higher plants.

  2010cites this paper
• Plant-Derived Anticancer Agents Used in Western and Oriental Medicine

  2010cites this paper
• Meisoindigo is a promising agent with in vitro and in vivo activity against human acute myeloid leukemia

  2010cites this paper
• In-vitro-Testung und Analytik innovativer DNA Polymerase-α-Hemmer, entwickelt für die topische Behandlung von Plattenepithelkarzinomen und Basaliomen

  2009cites this paper